|
|
|
| First Name: | Joan | | Last Name: | Amatniek | | Title: | Director, Clinical Development, Alzheimer's Disease | | Advanced Degrees: | MD, MSc | | Affiliation: | Ortho-McNeil Neurologics | | Department: | Medical Affairs | | Street Address 1: | 1125 Trenton-Harbourton Rd. | | City: | Titusville | | State/Province: | NJ | | Zip/Postal Code: | 08560 | Country/Territory: | U.S.A. | | Phone: | 609-730-2000 | | Fax: | 609-730-3406 | | Email Address: |  |
Disclosure:
(view policy)
|
Member reports the following financial or other potential conflicts of interest: [Last Modified: 24 May 2006]
I work on Alzheimer's drugs at Ortho-McNeil Neurologics and own Johnson and Johnson stock and stock options.
|
Aging Process, Parkinson Disease, Prion Diseases, Alzheimer Disease, Neurodevelopmental Disorders (Down syndrome, etc.), Tauopathies
|
A-beta PP/A-beta, Animal Models, Neurobiology, Bioinformatics/Statistics, Chemistry/Pharmacology, Diagnosis, Signal transduction, Stem cells, Genetics, Screening, Molecular and Cell biology, Apoptosis/Cell cycle, Brain imaging, Neuropathology, Clinical trials, Oxidative Stress, Protein structure/chemistry, Proteomics, Epidemiology, Tau/Cytoskeleton, Neurotransmission, Drug screening
|
Trained at Einstein, HUP, and Columbia as a physician, neurologist, epileptologist, and epidemiologist. Since fellowship, have worked in industry designing, leading the execution of, and communicating the results of phase IIIB and IV dementia trials and reviewing investigator initiated proposals at Janssen Pharmaceutica and Ortho-McNeil Neurologics. |
|
|
Home
